Evaluation of cardiovascular risk factors, events, and costs across four BMI categories

Obesity

Volumn 21, Issue 6, 2013, Pages 1284-1292

  Brixner, D I ^a   Bron, M ^b   Bellows, B K ^a   Ye, X ^a   Yu, J ^a,c   Raparla, S ^a,d   Oderda, G M ^a  

^a UNIVERSITY OF UTAH   (United States)

^b Takeda Pharmaceuticals International Inc   (United States)

^c TOURO UNIVERSITY CALIFORNIA   (United States)

^d HEALTHCORE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANGINA PECTORIS; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIABETES MELLITUS; EMPLOYER; FEMALE; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH SURVEY; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ICD-9; MAJOR CLINICAL STUDY; MALE; OBESITY; RISK ASSESSMENT; SEX RATIO; UNITED STATES;

EID: 84881327252     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20215     Document Type: Article

References (33)

1. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010; 121: e46-e215.
2. Third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 2002; 106: 3143-3421.
3. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716.
4. Onat A, Ceyhan K, Basar O, Erer B, Toprak S, Sansoy V,. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels-a prospective and cross-sectional evaluation. Atherosclerosis 2002; 165: 285-292.
5. Flint AJ, Hu FB, Glynn RJ, et al. Excess weight and the risk of incident coronary heart disease among men and women. Obesity (Silver Spring) 2010; 18: 377-383.
6. Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH,. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 2009; 9: 88-107.
7. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. The evidence report. Obes Res 1998; 6 (Suppl 2): 51S-209S.
8. Flegal KM, Carroll MD, Ogden CL, Curtin LR,. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010; 303: 235-241.
9. Finkelstein EA, DiBonaventura M, Burgess SM, Hale BC,. The costs of obesity in the workplace. J Occup Environ Med 2010; 52: 971-976.
10. Finkelstein EA, Fiebelkorn IC, Wang G,. National medical spending attributable to overweight and obesity: how much, and who's paying? Health Aff (Millwood) 2003;Suppl Web Exclusives:W3-219-W3-226.
11. Finkelstein E, Fiebelkorn C, Wang G,. The costs of obesity among full-time employees. Am J Health Promot 2005; 20: 45-51.
12. Gates DM, Succop P, Brehm BJ, Gillespie GL, Sommers BD,. Obesity and presenteeism: the impact of body mass index on workplace productivity. J Occup Environ Med 2008; 50: 39-45.
13. Said Q, Marx CM, Schwartz JS, Ben-Joseph R, Brixner DI,. Impact of body mass index on the incidence of cardiometabolic risk factors in ambulatory care settings over 5 years or more. Value Health 2010; 13: 265-272.
14. Brixner D, Ghate SR, McAdam-Marx C, Ben-Joseph R, Said Q,. Association between cardiometabolic risk factors and body mass index based on diagnosis and treatment codes in an electronic medical record database. J Manag Care Pharm 2008; 14: 756-767.
15. Nguyen NT, Nguyen XM, Wooldridge JB, Slone JA, Lane JS,. Association of obesity with risk of coronary heart disease: findings from the National Health and Nutrition Examination Survey, 1999-2006. Surg Obes Relat Dis 2010; 6: 465-469.
16. Palmer J, Kalsekar A, Boye K, Goodall G,. The impact of obesity on adverse cardiovascular outcomes in the general population and in patients with type 2 diabetes. Clin Med Endo 2009; 2: 43-69.
17. Malone DC, Boudreau DM, Nichols GA, et al. Association of cardiometabolic risk factors and prevalent cardiovascular events. Metab Syndr Relat Disord 2009; 7: 585-593.
18. Duh MS, Fulcher NM, White LA, et al. Costs associated with cardiovascular events in patients with hypertension in US managed care settings. J Am Soc Hypertens 2009; 3: 403-415.
19. Clarke PM, Gray AM, Briggs A, et al. A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). Diabetologia 2004; 47: 1747-1759.
20. Klein BE, Klein R, Lee KE,. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care 2002; 25: 1790-1794.
21. Alexander CM, Landsman PB, Teutsch SM, Haffner SM,. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003; 52: 1210-1214.
22. Boudreau DM, Malone DC, Raebel MA, et al. Health care utilization and costs by metabolic syndrome risk factors. Metab Syndr Relat Disord 2009; 7: 305-314.
23. Brixner D, Said Q, Kirkness C, Oberg B, Ben-Joseph R, Oderda G,. Assessment of cardiometabolic risk factors in a national primary care electronic health record database. Value Health 2007; 10 (S1): S29-S36.
24. Orzano AJ, Scott JG,. Diagnosis and treatment of obesity in adults: an applied evidence-based review. J Am Board Fam Pract 2004; 17: 359-369.
25. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003; 42: 1206-1252.
26. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care 2010; 33 (Suppl 1): S11-S61.
27. Nguyen NT, Nguyen XM, Lane J, Wang P,. Relationship between obesity and diabetes in a US adult population: findings from the national health and nutrition examination survey, 1999-2006. Obes Surg 2011;21:351-355.
28. Asche CV, Singer ME, Jhaveri M, Chung H, Miller A,. All-cause health care utilization and costs associated with newly diagnosed multiple sclerosis in the United States. J Manag Care Pharm 2010; 16: 703-712.
29. Zhao Y, Kuo TC, Weir S, Kramer MS, Ash AS,. Healthcare costs and utilization for Medicare beneficiaries with Alzheimer's. BMC Health Serv Res 2008; 8: 108-115.
30. Finkelstein EA, Trogdon JG, Cohen JW, Dietz W,. Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood) 2009; 28: w822-w831.
31. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012; 125: e2-e220.
32. Wallace JI, Schwartz RS, LaCroix AZ, Uhlmann RF, Pearlman RA,. Involuntary weight loss in older outpatients: incidence and clinical significance. J Am Geriatr Soc 1995; 43: 329-337.
33. Oderda G, Lieberman M, Asche CV, Brixner DI, eds. Use of electronic medical record (EMR) data in outcomes research. In: 10th Annual European Meeting of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR), Dublin, Ireland, 2007.